Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Sol-Gel Technologies Ltd. (SLGL) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Sol-Gel Technologies Ltd. (SLGL), most recent 12 months reported: revenue $19.39M, net loss $6.13M, free cash flow $275K. Latest balance sheet on file: liquid cash $24M. From SEC filings. Others in Pharmaceutical Preparations: ABEONA THERAPEUTICS INC. · Janux Therapeutics, Inc. · PRELUDE THERAPEUTICS INC · CASI PHARMACEUTICALS, INC. · SCYNEXIS, Inc. · Celularity Inc. · CytomX Therapeutics, Inc. · uniQure N.V.

Stock screener

Watchlist